Positive feedback from FDA reviewers in response to Pre-IND meeting package
August 14, 2017 13:56 ET
|
Qu Biologics
VANCOUVER, British Columbia, Aug. 14, 2017 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique platform of immunotherapies...